West Pharmaceutical Services Inc (WST)
390.03
-0.17
(-0.04%)
USD |
NYSE |
Apr 24, 13:48
West Pharmaceutical Services Free Cash Flow (Quarterly): 130.40M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 130.40M |
September 30, 2023 | 134.30M |
June 30, 2023 | 93.80M |
March 31, 2023 | 56.00M |
December 31, 2022 | 135.90M |
September 30, 2022 | 111.10M |
June 30, 2022 | 107.00M |
March 31, 2022 | 85.40M |
December 31, 2021 | 84.30M |
September 30, 2021 | 124.80M |
June 30, 2021 | 87.50M |
March 31, 2021 | 34.00M |
December 31, 2020 | 94.80M |
September 30, 2020 | 71.10M |
June 30, 2020 | 107.20M |
March 31, 2020 | 25.00M |
December 31, 2019 | 68.80M |
September 30, 2019 | 76.40M |
June 30, 2019 | 76.80M |
March 31, 2019 | 18.80M |
December 31, 2018 | 43.20M |
September 30, 2018 | 61.90M |
June 30, 2018 | 61.80M |
March 31, 2018 | 17.00M |
December 31, 2017 | 52.00M |
Date | Value |
---|---|
September 30, 2017 | 41.50M |
June 30, 2017 | 55.80M |
March 31, 2017 | -16.80M |
December 31, 2016 | 24.30M |
September 30, 2016 | 19.70M |
June 30, 2016 | 41.20M |
March 31, 2016 | -36.00M |
December 31, 2015 | 23.20M |
September 30, 2015 | 39.10M |
June 30, 2015 | 50.80M |
March 31, 2015 | -32.30M |
December 31, 2014 | 18.70M |
September 30, 2014 | 35.30M |
June 30, 2014 | 39.70M |
March 31, 2014 | -22.90M |
December 31, 2013 | 26.10M |
September 30, 2013 | 24.00M |
June 30, 2013 | 57.40M |
March 31, 2013 | -42.80M |
December 31, 2012 | 36.20M |
September 30, 2012 | 22.60M |
June 30, 2012 | 15.20M |
March 31, 2012 | -18.60M |
December 31, 2011 | 7.00M |
September 30, 2011 | 15.90M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
25.00M
Minimum
Mar 2020
135.90M
Maximum
Dec 2022
89.72M
Average
87.50M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
Becton Dickinson & Co | 725.00M |
Abbott Laboratories | 2.283B |
Masimo Corp | 51.80M |
Merit Medical Systems Inc | 54.46M |
Insulet Corp | 13.60M |